A Global Leader in Pharmaceuticals and Research

Granulation in Pharma Manufacturing
Granulation in Pharma Manufacturing

M/s Taj Pharma Group stands as a pioneering force in the pharmaceutical industry, known for its dedication to research-driven innovation and the delivery of high-quality products across the globe. Established in 2004, the company has swiftly risen to prominence as a fully integrated manufacturer specializing in Finished Pharmaceuticals (Non Beta & Beta Lactam Oral Solid Dosage Forms), Directly Compressible Granules (DC Granules), Pellets, Active Pharmaceutical Ingredients (API), and Intermediates.

With a mission to provide qualitative and affordable healthcare solutions, M/s Taj Pharma Group has strategically positioned itself in domestic and international markets, earning trust and acclaim across more than 27 countries.


State-of-the-Art Manufacturing Facilities

Taj Pharma India Ltd.: Excellence in Non-Beta Lactam Manufacturing

M/s Taj Pharma India Ltd. operates a world-class manufacturing facility that adheres to the highest standards of quality and compliance. This facility is:

  • EU-GMP, WHO-GMP Approved, and ISO 9001-2015 Certified, ensuring global recognition for quality and reliability.
  • Designed and operated in alignment with EU-GMP, MHRA, and PIC/S guidelines.
  • Equipped for large-scale production of tablets, capsules, dry syrup, effervescent tablets, and oncology-specific OSDs.

The facility is a hallmark of technological advancement, enabling Taj Pharma to meet the growing demand for innovative and affordable medicines worldwide.


Taj Pharma Laboratory LLP.: Pioneering Cephalosporin Manufacturing

Introducing the brand-new, state-of-the-art facility of M/s Taj Pharma Laboratory Pvt. Ltd., dedicated exclusively to Cephalosporin (Beta Lactam) products. This facility complies with the most stringent standards, including PICS, WHO, and EU guidelines, and specializes in the production of:

  • Tablets
  • Dry Syrups
  • Capsules
  • DC Granules

With cutting-edge technology and a focus on cGMP (Current Good Manufacturing Practices), this facility ensures the delivery of high-quality products at competitive prices, catering to both domestic and international markets.


Taj Pharma Industries LLP: Innovating API and Intermediate Manufacturing

M/s Taj Pharma Industries LLP. boasts a state-of-the-art Greenfield facility, comprising four dedicated blocks for the production of:

  1. APIs (Active Pharmaceutical Ingredients)
  2. Intermediates
  3. Fine Chemicals

Designed in strict adherence to the latest Environmental, Health, and Safety (EHS) guidelines and international regulatory standards, this facility exemplifies sustainability and quality. The company’s expertise in this domain allows it to serve a diverse range of industries while maintaining regulatory compliance and customer satisfaction.


Dedicated Facilities for Specialized Products

M/s Taj Pharma Group emphasizes specialization through dedicated facilities tailored for specific product categories. These include:

  1. Oncology Products – Tablets and Capsules
  2. Nephrology Products and Immunosuppressive Agents – Tablets and Capsules
  3. General Non-Beta Lactam OSDs – Tablets, Capsules, Dry Syrups, Pellets, DC Granules, and Sachets
  4. Cephalosporin (Beta Lactam) – Tablets, Capsules, Dry Syrups, DC Granules

This specialization ensures precision, quality, and efficiency in manufacturing, meeting diverse healthcare needs.


World-Class R&D and Innovation

M/s Taj Pharma Group houses a DSIR-approved Research and Development (R&D) center, a cornerstone of its success. This facility is dedicated to:

  • Developing new formulations and advanced drug delivery systems.
  • Conducting rigorous testing to ensure safety and efficacy.
  • Innovating processes for cost-effective and sustainable production.

The company’s commitment to R&D underpins its reputation as a research-driven organization, shaping the future of healthcare.


Global Footprints: Expanding Healthcare Horizons

M/s Taj Pharma Group’s products transcend geographical and socio-economic barriers, reaching patients in over 27 countries across Asia, Africa, the Middle East, and Latin America. Some of the key markets include:

  • Asia: India, Vietnam, Philippines, Sri Lanka, Afghanistan, and Nepal.
  • Africa: Nigeria, Ghana, Kenya, Ethiopia, and Uganda.
  • Middle East: Iran, Iraq, Yemen, and Syria.
  • Latin America: Bolivia, Dominican Republic, Costa Rica, and Venezuela.

Through a robust distribution network, M/s Taj Pharma Group ensures the availability of its products worldwide, enhancing global healthcare access.


Global Accreditations: A Testament to Excellence

M/s Taj Pharma Group is recognized by multiple international regulatory bodies, including:

  • DPML, Cote D’Ivoire
  • DIGEMID, Peru
  • FDA, Philippines
  • TFDA, Tanzania
  • NAFDAC, Nigeria
  • FDA-MOH, Vietnam
  • NMRA, Sri Lanka

These accreditations underscore the company’s adherence to global regulatory frameworks, ensuring safety, efficacy, and quality.


Commitment to Quality and Affordability

M/s Taj Pharma Group’s clear objective is to provide affordable, high-quality healthcare solutions. By combining state-of-the-art facilities, stringent quality controls, and a customer-centric approach, the company has carved a niche in the highly competitive pharmaceutical industry.


Why Choose M/s Taj Pharma Group?

  1. Research-Based Excellence: A commitment to innovation through cutting-edge R&D.
  2. Regulatory Compliance: Adherence to the strictest global standards, ensuring product safety and efficacy.
  3. Global Reach: A strong presence in over 27 countries, making healthcare accessible to millions.
  4. Diverse Product Portfolio: Specialization in Non-Beta Lactam, Beta Lactam, Oncology, and Nephrology products.
  5. Sustainability: Operations aligned with international EHS guidelines, prioritizing environmental and societal well-being.